Stay updated on Pembrolizumab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.3 to v3.5.4, indicating a new release of the page assets.
    Difference
    0.0%
    Check dated 2026-05-17T09:00:08.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s displayed revision/build number has been updated from **v3.5.2** to **v3.5.3** for the ClinicalTrials.gov interface.
    Difference
    0.0%
    Check dated 2026-04-25T18:28:14.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:22:07.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T19:52:22.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-06T17:52:03.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    The page history shows a new revision entry (v3.4.2) replacing v3.4.1, with no other content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:48:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.